齐碳科技有限公司

齐碳科技有限公司

齐碳科技拥有国际一流的跨学科研发团队，涵盖蛋白工程、电子电路、生物芯片、人工智能等技术领域，用颠覆式创新的硬核科技将基因测序从PC时代带入到移动时代，建立起连接碳基生命与硅基生命的桥梁。齐碳科技于2020年9月成功发布了国内首台全自主知识产

Founded 2016 China

China 8 employees Series C Total: $1.34B Biotechnology, Health Care

Qitan Technology is a biotechnology startup founded in 2016, focused on revolutionizing genome sequencing technology. Utilizing nanopores, the company has developed a groundbreaking approach to sequence individual nucleic acid molecules. This pioneering method enables single-molecule sequencing with long read lengths and real-time output. Notably, it offers a low-cost, compact, and user-friendly instrument, eliminating the need for complex library preparation, making it a cost-effective solution for genome sequencing. The company's advanced technology has garnered significant attention, leading to a noteworthy CNY100.00M Series C investment at 28 December 2023. This round of funding was backed by prominent investors including 成都天府国际生物城投资开发有限公司, Chengdu High-tech Ceyuan Capital, and Guosheng Capital, signifying the confidence and support Qitan Technology has secured within the investment landscape. With a focus on biotechnology and health care industries, Qitan Technology's innovative genome sequencing technology has broad applications in biological research and clinical medicine. The technology's ability to detect nucleic acid modifications directly expands its utility in instant diagnosis, metagenomics, epigenetics, RNA studies, and transcriptomics, positioning the company at the forefront of the genomics sector. In conclusion, Qitan Technology's disruptive approach and recent Series C funding exemplify its potential to reshape the genomics landscape, positioning it as a compelling prospect for venture capital investment.

Funding Stage	Amount	Investors	Lead Investors	Date
Series C	CNY100.00M	3	成都天府国际生物城投资开发有限公司, Chengdu High-tech Ceyuan Capital +1	28 Dec 2023
Series C	CNY700.00M	3	BioTrack Capital, Huagai Capital +1	23 Dec 2022
Series B	CNY400.00M	8	Gaorong Capital, CDH Investments +6	08 Jun 2021
Series A	CNY100.00M	3	Gaorong Capital, 浙江银杏谷投资有限公司 +1	13 May 2020
Venture Round	CNY40.00M	2	Baidu Venture, Yahui Precision Medicine Fund	08 Aug 2019
Series A	CNY3.00M	4	Empower Investment, Baidu Venture +2	01 Apr 2017
Angel Round	Undisclosed	1	Empower Investment	01 Feb 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Series C

CNY100.00M

成都天府国际生物城投资开发有限公司, Chengdu High-tech Ceyuan Capital +1

28 Dec 2023

Series C

CNY700.00M

BioTrack Capital, Huagai Capital +1

23 Dec 2022

Series B

CNY400.00M

Gaorong Capital, CDH Investments +6

08 Jun 2021

Series A

CNY100.00M

Gaorong Capital, 浙江银杏谷投资有限公司 +1

13 May 2020

Venture Round

CNY40.00M

Baidu Venture, Yahui Precision Medicine Fund

08 Aug 2019

Series A

CNY3.00M

Empower Investment, Baidu Venture +2

01 Apr 2017

Angel Round

Undisclosed

Empower Investment

01 Feb 2017

FAQ About 齐碳科技有限公司

齐碳科技有限公司 was founded in 2016.

齐碳科技有限公司 is headquartered in China.

齐碳科技有限公司 operates in Biotechnology and Health Care.

齐碳科技有限公司 has approximately 8 employees.

齐碳科技有限公司 has completed 7 funding rounds, raising a total of $1.34B. The latest funding stage is Series C.

Top alternatives and competitors to 齐碳科技有限公司 include AnimalBiome, Paragon Genomics, Belun Technology Company Limited, Endocision, HebeCell Corp. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

齐碳科技有限公司 and AnimalBiome are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About 齐碳科技有限公司

Funding Rounds & Investors (7)

齐碳科技有限公司 Alternatives & Competitors

FAQ About 齐碳科技有限公司